Concepedia

Tuberculosis Vaccine Development

Tuberculosis Vaccine Development is a scholarly research endeavor constituting the systematic design, formulation, and evaluation of immunological interventions specifically aimed at preventing Mycobacterium tuberculosis infection through the creation of novel or improved prophylactic or therapeutic vaccine candidates within the broader domain of infectious disease immunization strategies.

1.1K

Publications

54.2K

Citations

4.3K

Authors

1.1K

Institutions

Publications per year

2017–2026

276

Parents

Publications

1.1K

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

, , +14

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

Kris Huygen, Jean Content, Olivier Denis et al. · Nature Medicine · 1996 · 630 citations

, , +14

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 595 citations · Full text

, , +17

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin

Leander Grode · Journal of Clinical Investigation · 2005 · 552 citations · Full text

, , +17

A multistage tuberculosis vaccine that confers efficient protection before and after exposure

Claus Aagaard, Truc Thi Kim Thanh Hoang, Jes Dietrich et al. · Nature Medicine · 2011 · 525 citations · Full text

, , +14

1–5 of 1.1K

Authors

4.3K

  1. PA
    Peter Andersen

    Statens Serum Institut, Denmark

    40 publications · 4.8K citations

    33

    h-index

  2. HM
    Helen McShane

    University of Oxford, United Kingdom

    42 publications · 3.4K citations

    29

    h-index

  3. IM
    Ian M. Orme

    Colorado State University, United States

    31 publications · 3.4K citations

    24

    h-index

  4. SH
    Stefan H. E. Kaufmann

    Max Planck Institute for Infection Biology, Germany

    27 publications · 2K citations

    23

    h-index

  5. RN
    Rhea N. Coler

    Infectious Disease Research Institute, United States

    26 publications · 2.1K citations

    22

    h-index

1–5 of 4.3K

Institutions

1.1K

  1. Statens Serum Institut

    Copenhagen, Denmark

    33 h-index

    189 publications

    22K citations

  2. Aeras

    Rockville, United States

    32 h-index

    162 publications

    15.6K citations

  3. Colorado State University

    Fort Collins, United States

    30 h-index

    166 publications

    10.5K citations

  4. University of Oxford

    Oxford, United Kingdom

    29 h-index

    272 publications

    13.1K citations

  5. London School of Hygiene & Tropical Medicine

    London, United Kingdom

    28 h-index

    122 publications

    7.8K citations

  6. Infectious Disease Research Institute

    Seattle, United States

    27 h-index

    192 publications

    18.4K citations

  7. Jenner Institute

    Oxford, United Kingdom

    26 h-index

    234 publications

    10.8K citations

  8. Max Planck Institute for Infection Biology

    Berlin, Germany

    24 h-index

    77 publications

    7.3K citations

1–8 of 1.1K

Venues

  1. Vaccine

    156 publications · 7.5K citations

    50

    h-index

  2. Infection and Immunity

    IAI · 67 publications · 6.5K citations

    46

    h-index

  3. PLoS ONE

    59 publications · 2.7K citations

    32

    h-index

  4. Tuberculosis

    46 publications · 1.7K citations

    25

    h-index

  5. PubMed

    Repository · 60 publications · 2K citations

    25

    h-index

1–5